JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.07B |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.82B |
| 3 |
AT&T
T
|
+$779M |
| 4 |
Gilead Sciences
GILD
|
+$774M |
| 5 |
Eli Lilly
LLY
|
+$590M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
MON
Monsanto Co
MON
|
+$890M |
| 3 |
CVS Health
CVS
|
+$779M |
| 4 |
SLB Ltd
SLB
|
+$600M |
| 5 |
Chevron
CVX
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Healthcare | 12.01% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
PUT
PepsiCo
PEP
$189B
| $8.22M | ﹤0.01% |
88,100
-7,000
| -7% | -$669K |
|
1977
PUT
Mondelez International
MDLZ
$78.9B
| $8.2M | ﹤0.01% |
199,200
| – | – |
|
|
VAR
1978
DELISTED
Varian Medical Systems, Inc.
VAR
| $8.19M | ﹤0.01% |
110,780
-59,775
| -35% | -$4.68M |
|
|
BRFS
1979
DELISTED
BRF SA
BRFS
| $8.19M | ﹤0.01% |
391,600
-498,194
| -56% | -$10.5M |
|
1980
Federal Signal
FSS
$7.86B
| $8.18M | ﹤0.01% |
548,380
-5,942
| -1% | -$92.4K |
|
1981
CVB Financial
CVBF
$4.02B
| $8.14M | ﹤0.01% |
462,054
-229,384
| -33% | -$3.77M |
|
1982
CALL
Transocean
RIG
$6.49B
| $8.14M | ﹤0.01% |
504,800
-120,000
| -19% | -$2.16M |
|
1983
CALL
IBM
IBM
$225B
| $8.13M | ﹤0.01% |
52,300
-407,940
| -89% | -$65.6M |
|
1984
Grupo Cibest SA
CIB
$23.1B
| $8.12M | ﹤0.01% |
188,874
-14,208
| -7% | -$611K |
|
|
DCUA
1985
DELISTED
DOMINION RESOURCES INC. CORP UNIT 2013 SER A (VA)
DCUA
| $8.1M | ﹤0.01% |
151,230
-7,016
| -4% | -$394K |
|
1986
Flex
FLEX
$45.2B
| $8.1M | ﹤0.01% |
950,100
-358,334
| -27% | -$3.3M |
|
1987
Timken Company
TKR
$8.91B
| $8.1M | ﹤0.01% |
221,446
-205,366
| -48% | -$8.19M |
|
1988
Alkermes
ALKS
$8.26B
| $8.07M | ﹤0.01% |
125,377
+23,666
| +23% | +$1.45M |
|
|
IPHS
1989
DELISTED
Innophos Holdings, Inc.
IPHS
| $8.06M | ﹤0.01% |
153,130
+78,394
| +105% | +$4.26M |
|
1990
Gentex
GNTX
$5.04B
| $8.04M | ﹤0.01% |
489,732
-66,853
| -12% | -$1.17M |
|
1991
Pegasystems
PEGA
$5.44B
| $8.04M | ﹤0.01% |
702,152
-58,848
| -8% | -$650K |
|
1992
Amphastar Pharmaceuticals
AMPH
$869M
| $8.02M | ﹤0.01% |
456,367
-160,583
| -26% | -$2.5M |
|
1993
FMC
FMC
$1.3B
| $8.02M | ﹤0.01% |
175,891
-51,605
| -23% | -$2.56M |
|
|
AET
1994
CALL
DELISTED
Aetna Inc
AET
| $7.97M | ﹤0.01% |
62,500
+62,400
| +62,400% | +$7.12M |
|
|
KE
1995
Kimball Electronics
KE
$607M
| $7.95M | ﹤0.01% |
545,200
-53,825
| -9% | -$777K |
|
1996
Tetra Tech
TTEK
$9.06B
| $7.93M | ﹤0.01% |
1,547,410
+218,680
| +16% | +$1.12M |
|
|
WELL.PRI
1997
DELISTED
Welltower Inc.
WELL.PRI
| $7.92M | ﹤0.01% |
133,200
-5,600
| -4% | -$359K |
|
1998
Preferred Bank
PFBC
$1.27B
| $7.92M | ﹤0.01% |
263,375
+6,400
| +2% | +$183K |
|
1999
WesBanco
WSBC
$4.05B
| $7.88M | ﹤0.01% |
231,715
-3,327
| -1% | -$108K |
|
|
GPOR
2000
DELISTED
Gulfport Energy Corp.
GPOR
| $7.88M | ﹤0.01% |
195,737
+92,272
| +89% | +$4.23M |
|
Similar funds
JP Morgan Chase's Q2 2015 Portfolio in Review
As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
- JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
- JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
- JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
- JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
- JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.
Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.